Covid-19 roundup: Merck submits molnupiravir for EUA; India resumes vaccine exports after Delta surge

Merck’s oral antiviral drug for Covid-19 has been submitted to the FDA for emergency use authorization, the company announced Monday morning.

The company, which collaborated with Ridgeback Biotherapeutics, announced last week that molnupiravir reduced death and hospitalizations by 50%. The submission for EUA is based on...

Click to view original post